v3.25.2
Balance Sheet Details (Tables)
 9 Months Ended
Jul. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Cash and Cash Equivalents
Cash, Cash Equivalents and Restricted Cash
As of
July 31, 2025October 31, 2024
In millions
Cash and cash equivalents $4,571 $14,846 
Restricted cash(1)
126 259 
Total$4,697 $15,105 
(1)    The Company included restricted cash in Other current assets in the accompanying Condensed Consolidated Balance Sheets.
Schedule of Inventory
Inventory
 As of
 July 31, 2025October 31, 2024
 In millions
Purchased parts and fabricated assemblies$4,455 $5,441 
Finished goods2,708 2,369 
Total $7,163 $7,810 
Schedule of Property, Plant and Equipment
Property, Plant and Equipment, net
 As of
 July 31, 2025October 31, 2024
 In millions
Land$306 $66 
Buildings and leasehold improvements2,088 1,696 
Machinery and equipment, including equipment held for lease10,607 10,392 
Gross property, plant and equipment13,001 12,154 
Accumulated depreciation(6,883)(6,490)
Property, plant and equipment, net$6,118 $5,664 
Schedule of Changes in Aggregate Product Warranty Liabilities
The Company's aggregate product warranty liabilities and changes for the nine months ended July 31, 2025, and the fiscal year ended October 31, 2024 were as follows:
 As of
July 31, 2025October 31, 2024
 In millions
Balance at beginning of period$301 $318 
Charges162 173 
Adjustments related to pre-existing warranties(53)(5)
Settlements made (125)(185)
Balance at end of period(1)
$285 $301 
(1)The Company included the current portion in Other accrued liabilities, and amounts due after one year in Other non-current liabilities in the accompanying Consolidated Balance Sheets.
Schedule of Severance Liability
The following table presents the activity related to the Company’s severance liability for the period indicated:
 As of
July 31, 2025
 In millions
Balance at beginning of period$49 
Severance charges256 
Cash paid and other(99)
Balance at end of period$206 
The following table presents severance charges as included in the Condensed Consolidated Statements of Earnings for the periods indicated:
 For the three months ended July 31, 2025For the nine months ended July 31, 2025
 In millions
Cost of sales— $63 
Research and development— 31 
Selling, general and administrative— 147 
Acquisition, disposition and other charges15 15 
Total severance charges$15 $256 
Schedule of Accounts Receivable, Net
A summary of accounts receivable, net, including unbilled receivables was as follows:
As of
July 31, 2025October 31, 2024
In millions
Accounts receivable$5,260 $3,236 
Unbilled receivables414 324 
Allowances(18)(10)
Total$5,656 $3,550 
Schedule of Trade Receivables Sold and Cash Received
The allowances for credit losses related to accounts receivable and changes for the nine months ended July 31, 2025, and the fiscal year ended October 31, 2024 were as follows:
 As of
 July 31, 2025October 31, 2024
 In millions
Balance at beginning of period$10 $37 
Provision for credit losses20 41 
Adjustments to existing allowances, including write offs(12)(68)
Balance at end of period$18 $10 
Schedule of Contract Liabilities
Contract liabilities consist of deferred revenue and customer deposits. A summary of contract liabilities were as follows:
 As of
 July 31, 2025October 31, 2024
 LocationIn millions
Customer depositsOther accrued liabilities$580 $289 
Customer deposits - non-currentOther non-current liabilities73 7 
Total customer deposits$653 $296 
Deferred revenueDeferred revenue$5,311 $3,904 
Deferred revenue - non-currentOther non-current liabilities4,837 3,578 
Total deferred revenue$10,148 $7,482